Literature DB >> 23857405

Successful crizotinib retreatment after crizotinib-induced interstitial lung disease.

Satoru Yanagisawa1, Akira Inoue, Akira Koarai, Manabu Ono, Tokiwa Tamai, Masakazu Ichinose.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23857405     DOI： 10.1097/JTO.0b013e318293dfc1

Source DB:  PubMed          Journal:  J Thorac Oncol        ISSN： 1556-0864            Impact factor:   15.609


× No keyword cloud information.
  8 in total

1.  Managing treatment-related adverse events associated with Alk inhibitors.

Authors:  J M Rothenstein; N Letarte
Journal:  Curr Oncol       Date:  2014-02       Impact factor: 3.677

2.  Alectinib as a treatment option following recovery from crizotinib-induced interstitial lung disease in patients with anaplastic lymphoma kinase-positive advanced non-small-cell lung cancer.

Authors:  Shigenari Nukaga; Katsuhiko Naoki; Tetsuro Kamo; Keita Masuzawa; Hiroyuki Yasuda; Kenzo Soejima; Tomoko Betsuyaku
Journal:  Mol Clin Oncol       Date:  2016-03-30

3.  Acute interstitial lung disease in a patient with anaplastic lymphoma kinase-positive non-small-cell lung cancer after crizotinib therapy.

Authors:  Vinayak V Maka; Uma Maheshwari Krishnaswamy; N Anil Kumar; Rohith Chitrapur; Nalini Kilara
Journal:  Oxf Med Case Reports       Date:  2014-04-08

4.  Successful crizotinib rechallenge after crizotinib-induced organizing pneumonia in anaplastic lymphoma kinase-rearranged non-small cell lung cancer.

Authors:  Nobuhiro Asai; Toyoharu Yokoi; Etsuro Yamaguchi; Akihito Kubo
Journal:  Case Rep Oncol       Date:  2014-09-27

5.  Acute Interstitial Lung Disease Induced by Rechallenge with Ceritinib.

Authors:  Takamasa Hotta; Tamio Okimoto; Megumi Hamaguchi; Yukari Tsubata; Takeshi Isobe
Journal:  Intern Med       Date:  2019-09-18       Impact factor: 1.271

6.  Synergistic Effects of Crizotinib and Temozolomide in Experimental FIG-ROS1 Fusion-Positive Glioblastoma.

Authors:  Arabinda Das; Ron Ron Cheng; Megan L T Hilbert; Yaenette N Dixon-Moh; Michele Decandio; William Alex Vandergrift; Naren L Banik; Scott M Lindhorst; David Cachia; Abhay K Varma; Sunil J Patel; Pierre Giglio
Journal:  Cancer Growth Metastasis       Date:  2015-12-01

7.  Successful alectinib treatment after crizotinib-induced interstitial lung disease.

Authors:  Satoru Fujiuchi; Yuka Fujita; Takaaki Sasaki; Yoshinobu Ohsaki
Journal:  Respirol Case Rep       Date:  2016-04-07

8.  Peritumoural ground-glass opacity associated with tumour pseudoprogression in a patient with non-small cell lung cancer treated with nivolumab.

Authors:  Ryoji Kato; Hidetoshi Hayashi; Junko Tanizaki; Kaoru Tanaka; Masayuki Takeda; Kazuhiko Nakagawa
Journal:  ESMO Open       Date:  2017-03-28
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.